ArticleThe Prostate2020

Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells.

Aisha Naeem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.